In our study using a large, uniform cohort (n > 900) comprised of patients with stage I lung adenocarcinoma, we have demonstrated that ERα expression is an independent risk factor of disease recurrence, especially in male patients with pT1a status (HR = 3.66). This evidence concerns the gene ESR1 and lung adenocarcinoma.